New Disorders Workgroup Winter Webinar Series Part Three: On the Horizon: A Review of Up and Coming Disorders and the Future of the RUSP
The Association of Public Health Laboratories (APHL) Newborn Screening Technical assistance and Evaluation Program (NewSTEPs) is pleased to announce the final webinar in the New Disorders Workgroup Webinar Series. This three-part webinar series provides updates from programs screening for disorders not currently on the RUPS, both as pilot programs and as components of universal screening. This series ends with a discussion of future disorders that have been nominated for review by the Advisory Committee on Heritable Disorders in Newborn and Children (ACHDNC) and/or are in current pilots.
This webinar highlights disorders that are on the horizon for RUPS nomination and presents both research and advocacy efforts in expanding newborn screening for additional disorders. This webinar helps programs prepare for potential upcoming disease additions.
Objectives:
At the conclusion of the program, the participant will be able to:
- Review disorders on the horizon for RUSP nomination
- Describe current research and pilot activities around these disorders
- Review Metachromatic Leukodystrophy (MLD) RUSP nomination activities and ScreenPlus pilot activities
- Discuss future recommendations for RUSP nomination
Speakers:
Amy Brower, PhD, Associate Director, Americal College of Medical Genetics and Genomics
Joe Orsini, PhD, Director of Operations, New York State Newborn Screening Program
Dean, President and Co-Founder, MLD Foundation
Continuing Education
APHL is approved as a provider for continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E Program, Florida, and CPH recertification P.A.C.E is accepted by all licensures states except Florida. If approved, this webinar will provide 1.0 contact hour for participants who successfully complete this webinar.
This resource is supported by the Health Resources and Services Administration (HRSA) of the U.S. Department of Health and Human Services (HHS) under grant # U22MC24078. This information or content and conclusions are those of the authors and should not be construed as the official position or policy of, nor should any endorsements be inferred by HRSA, HHS, or the US Government.